Nivolumab for Patients With High-Risk Oral Leukoplakia

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Elective versus therapeutic neck dissection in node-negative oral cancer: Evidence from five randomized controlled trials2015 · 123 citations
2. 2Randomized, Double-Blind, Placebo-Controlled Phase IIB Trial of the Cyclooxygenase Inhibitor Ketorolac as an Oral Rinse in Oropharyngeal Leukoplakia2004 · 103 citations
3. 3Untitled2018 · 2 citations
4. 4Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial2016 · 1,741 citations
5. 5A modified classification and staging system for oral leukoplakia2000 · 98 citations